142 related articles for article (PubMed ID: 4133131)
1. [Complex treatment of toxic goiter].
Kal'chenko II; Nechiporenko FP
Sov Med; 1973 Oct; 36(10):99-102. PubMed ID: 4133131
[No Abstract] [Full Text] [Related]
2. [Current concepts in the treatment of Basedow's disease].
Jaffiol C; Baldet L
Sem Hop; 1975 Sep 10-20; 51(37-38):2265-7. PubMed ID: 56038
[No Abstract] [Full Text] [Related]
3. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
Berg GE; Michanek AM; Holmberg EC; Fink M
J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
[TBL] [Abstract][Full Text] [Related]
4. [Basedow's disease].
Shizume K
Naika; 1971 Jun; 27(6):1156-8. PubMed ID: 4103929
[No Abstract] [Full Text] [Related]
5. [Current approaches to the treatment of diffuse toxic goiter].
Balabolkin MI
Ter Arkh; 1995; 67(10):15-8. PubMed ID: 8779095
[No Abstract] [Full Text] [Related]
6. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
Rasmussen AK; Feldt-Rasmussen UF
Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
[No Abstract] [Full Text] [Related]
7. [Treatment of Basedow's disease].
Bürgi H
Rev Med Suisse Romande; 1975 May; 95(5):325-43. PubMed ID: 52173
[No Abstract] [Full Text] [Related]
8. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
Mitouze J; Jaffiol C; Baldet L; Ghachem M
Rev Fr Endocrinol Clin; 1972; 13(4):339-61. PubMed ID: 4122472
[No Abstract] [Full Text] [Related]
9. [Surgical treatment of Basedow's disease. Review of a series of 823 operations (author's transl)].
Blondeau P; Wolfeler L; Rene L
Ann Chir; 1978 Dec; 32(10):779-87. PubMed ID: 86322
[No Abstract] [Full Text] [Related]
10. [Graves' disease--selection of therapeutic modalities].
Ito K
Nihon Rinsho; 1980; 38(3):1672-6. PubMed ID: 6156254
[No Abstract] [Full Text] [Related]
11. [Dynamics of protein-bound iodine and iodine extracted with butanol in diffuse toxic goiter patients treated with radioactive iodine (I-131) after preliminary treatment with mercazolyl and reserpine].
Anestiadi ZG
Probl Endokrinol (Mosk); 1969; 15(1):6-10. PubMed ID: 4185484
[No Abstract] [Full Text] [Related]
12. [Basedow's disease. Individual therapy of is great significance].
Hörmann R
MMW Fortschr Med; 2005 Sep; 147(35-36):47. PubMed ID: 16180573
[No Abstract] [Full Text] [Related]
13. [The ocular risks of treatment of Basedow's disease (author's transl)].
Mornex R; Pousset G; Guinet P
Ann Endocrinol (Paris); 1974; 35(1):74-8. PubMed ID: 4138066
[No Abstract] [Full Text] [Related]
14. Graves' disease in children.
Hung W
Curr Ther Endocrinol Metab; 1997; 6():77-81. PubMed ID: 9174708
[No Abstract] [Full Text] [Related]
15. [Basedow's disease: surgery, the choice treatment].
Chiampo L
Minerva Endocrinol; 1987; 12(1):49-53. PubMed ID: 2438548
[No Abstract] [Full Text] [Related]
16. [Effect of radical treatment of Basedow's disease on the ocular symptoms].
Lederer J
Ann Endocrinol (Paris); 1974; 35(1):79-81. PubMed ID: 4138226
[No Abstract] [Full Text] [Related]
17. Antithyroid drugs.
Nebesio TD; Eugster EA
N Engl J Med; 2005 May; 352(21):2246-7; author reply 2246-7. PubMed ID: 15926207
[No Abstract] [Full Text] [Related]
18. [Mechanism of the antithyroid effect of reserpine in patients with diffuse toxic goiter].
Komarovskaia RP; Potin VV; Ugoleva SV
Probl Endokrinol (Mosk); 1970; 16(4):9-14. PubMed ID: 4102831
[No Abstract] [Full Text] [Related]
19. Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities.
Hegedüs L
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):355-71, ix. PubMed ID: 19328416
[TBL] [Abstract][Full Text] [Related]
20. [Contemporary treatment of diffuse toxic goiter].
Spesivtseva VG; Liashko KIa
Sov Med; 1970; 33(8):103-11. PubMed ID: 4099132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
